These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Diabetes mellitus as a risk factor for arteriosclerosis]. Maeda E; Yoshino G; Kasuga M Nihon Rinsho; 1993 Aug; 51(8):2170-6. PubMed ID: 8411688 [TBL] [Abstract][Full Text] [Related]
23. The influence of hypertension and other hemodynamic factors in atherogenesis. Chobanian AV Prog Cardiovasc Dis; 1983; 26(3):177-96. PubMed ID: 6359267 [No Abstract] [Full Text] [Related]
24. [Overview: Atherogenic lipoproteins and their clinical significance]. Shirai K Nihon Rinsho; 2004 Dec; 62 Suppl 12():5-9. PubMed ID: 15658249 [No Abstract] [Full Text] [Related]
25. Mechanisms regulating the vascular smooth muscle Na/H exchanger (NHE-1) in diabetes. Hannan KM; Little PJ Biochem Cell Biol; 1998; 76(5):751-9. PubMed ID: 10353708 [TBL] [Abstract][Full Text] [Related]
26. Diabetes, lipoproteins, and atherosclerosis. Schonfeld G Metabolism; 1985 Dec; 34(12 Suppl 1):45-50. PubMed ID: 3906360 [TBL] [Abstract][Full Text] [Related]
27. Atherosclerosis, the major complication of diabetes. Steiner G Adv Exp Med Biol; 1985; 189():277-97. PubMed ID: 4036715 [No Abstract] [Full Text] [Related]
28. Nutritional factors in extracoronary atherosclerosis. Nestel P Monogr Atheroscler; 1986; 14():230-4. PubMed ID: 3736562 [No Abstract] [Full Text] [Related]
29. Atherogenesis and inflammation. Jang IK; Lassila R; Fuster V Eur Heart J; 1993 Dec; 14 Suppl K():2-6. PubMed ID: 8131783 [TBL] [Abstract][Full Text] [Related]
30. Interactions of lipoproteins with vascular intima in atherosclerosis. Smith EB Biochem Soc Trans; 1991 Feb; 19(1):235-41. PubMed ID: 2037159 [No Abstract] [Full Text] [Related]
31. [Atherosclerosis. Description and mechanisms. Part 2: mechanisms]. Capron L Rev Neurol (Paris); 1983; 139(4):239-50. PubMed ID: 6612139 [No Abstract] [Full Text] [Related]
32. Vascular cell interactions with special reference to the pathogenesis of atherosclerosis. Davies PF Lab Invest; 1986 Jul; 55(1):5-24. PubMed ID: 3014215 [No Abstract] [Full Text] [Related]
33. Fibrous cap formation or destruction--the critical importance of vascular smooth muscle cell proliferation, migration and matrix formation. Newby AC; Zaltsman AB Cardiovasc Res; 1999 Feb; 41(2):345-60. PubMed ID: 10341834 [TBL] [Abstract][Full Text] [Related]
34. [Involvement of adiponectin in the pathogenesis of hypertension and hypertensive target-organ damage]. Arita Y; Matsuzawa Y Nihon Rinsho; 2004 Mar; 62 Suppl 3():222-7. PubMed ID: 15171373 [No Abstract] [Full Text] [Related]
35. [Cellular and extracellular changes in the regression of experimentally-induced arteriosclerosis and their relevance for the regression of arteriosclerosis in humans]. Massmann J Z Gesamte Inn Med; 1986 Jul; 41(14):400-5. PubMed ID: 3765741 [TBL] [Abstract][Full Text] [Related]
36. [The role of collagen matrix in atherogenesis]. Sakata N; Jimi S; Fujimitsu K; Takebayashi S Nihon Rinsho; 1993 Aug; 51(8):1967-73. PubMed ID: 8411658 [TBL] [Abstract][Full Text] [Related]
37. [The cellular mechanisms of atherogenesis]. Haller H Dtsch Med Wochenschr; 1993 May; 118(20):755-6. PubMed ID: 8500422 [No Abstract] [Full Text] [Related]
38. The pathogenesis of atherosclerosis--an update. Ross R N Engl J Med; 1986 Feb; 314(8):488-500. PubMed ID: 3511384 [No Abstract] [Full Text] [Related]
39. [The pathogenesis of atherosclerosis. Contribution from a cytobiological viewpoint]. Baumgartner HR Schweiz Med Wochenschr; 1977 May; 107(21):717-22. PubMed ID: 559346 [No Abstract] [Full Text] [Related]